Stifel Maintains Buy on IDEXX Laboratories, Lowers Price Target to $675

Benzinga Newsdesk www.benzinga.com Negative 75.8%

Neg 75.8% Neu 0% Pos 0%

Stifel analyst Jonathan Block maintains IDEXX Laboratories (NASDAQ:IDXX) with a Buy and lowers the price target from $775 to $675.